+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years +
All Genders
ID06581965

The DISTINCT Trial Personalized Thrombosis Prevention Compared to Standard Care After Total Hip or Knee Replacement Surgery

Led by Leiden University Medical Center · Updated on 2026-09-08

10078

Participants Needed

13

Research Sites

39 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate individualized thrombosis prevention after total hip or knee replacement surgery. Despite standard blood thinner treatment given to all patients to prevent venous thromboembolism VTE, some still develop clots while others experience bleeding. The study investigates whether customizing the type and duration of blood thinner treatment based on each patients medical history can reduce both clotting and bleeding risks compared to the standard uniform approach. Participants are grouped by their predicted VTE risk using the TRiPplasty score into low, intermediate, or high risk. Low-risk patients are randomized to receive either standard prophylaxis or a shortened treatment only during hospital stay. High-risk patients are randomized to receive standard treatment or a higher dose for six weeks. Intermediate-risk patients are observed without treatment changes. Blood thinners used include types of LMWH or DOACs given according to local standards, with dosing timing specified after surgery. Participants complete four questionnaires one before surgery and follow-ups at 2 weeks, 6 weeks, and 3 months post-surgery to report any VTE or bleeding events. An additional questionnaire is sent one year after surgery if certain complications occurred, assessing quality of life and joint function. No extra hospital visits are required. The main outcomes measured are symptomatic VTE and major bleeding within 90 days post-surgery, along with other health and quality of life measures up to one year.

CONDITIONS

Brief Title

inDividual, Targeted thrombosIS Prophylaxis Versus the Standard 'One Size Fits All' Approach in Patients Undergoing Total hIp or Total kNee replaCemenT

Research Team

B

Banne Nemeth, dr

R

Ruben Y Kok, drs

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here